Blackstone Inc Compass Therapeutics, Inc. Transaction History
Blackstone Inc
- $24.2 Billion
- Q1 2024
A detailed history of Blackstone Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 6,189,551 shares of CMPX stock, worth $6.56 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,189,551
Previous 6,189,551
-0.0%
Holding current value
$6.56 Million
Previous $9.66 Million
26.93%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$23.7 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$11.8 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$6.88 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$6.39 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA5.56MShares$5.89 Million0.63% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $107M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...